Health care stocks were declining premarket Friday, with The Health Care Select Sector SPDR Fund (XLV) 0.6% lower and the iShares Biotechnology ETF (IBB) down 1.1%.
Walgreens Boots Alliance (WBA) shares were up over 13% after the company reported fiscal Q1 results that topped analyst expectations, with a year-over-year increase in revenue.
Royalty Pharma (RPRX) shares were up more than 4% after the company said it has agreed to acquire its external manager, RP Management for about $1.10 billion, including 24.5 million in shares that will vest over five to nine years, about $100 million in cash, and the assumption of $380 million of debt.
Neogen (NEOG) shares were down more than 9% after the company lowered its fiscal 2025 revenue guidance.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。